Is AURA stock safe? | Glauxie AI

Q: Is AURA stock safe?

Aura Biosciences, Inc. (AURA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Elisabet de los Pinos. Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of... Employees: 113.

Q: What are the risks of investing in AURA?

Identify key risks of investing in AURA — debt, competition, volatility, and sector headwinds.

Q: Is AURA a good long-term investment?

Evaluate AURA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does AURA have?

Review AURA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is AURA stock safe?

🦉

Aura Biosciences, Inc. (AURA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOElisabet de los Pinos

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the...

Key Executives

Name	Title
Amy Elazzouzi	Interim Principal Accounting Officer, Senior Vice President of Finance & Treasurer
Anthony Daniels	Vice President & Therapeutic Area of Head Ocular Oncology
Anthony S. Gibney	Chief Financial & Business Officer
Conor Kilroy	Chief Legal Officer & Secretary
Elisabet de los Pinos	Founder, Chief Executive Officer, President & Director
Jill Hopkins	Chief Medical Officer & President of Research and Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

AURA Profile Financials

What are the risks of investing in AURA? Is AURA a good long-term investment? How much debt does AURA have?